Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curosurf vs Curosurf plus fluticasone in infants with hyaline membrane disease
IRCT138808031378N8Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Poractant alfa and fluticasone in hyaline membrane disease (RDS) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Jun 2011; status: completed.
02
Drugs
Poractant alfafluticasone
03
Conditions
hyaline membrane disease (RDS)
Beyond the preview
Go deeper on IRCT138808031378N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138808031378N8.